Literature DB >> 27151068

Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study.

Susanne Brandstetter1, Gertraud Riedelbeck1, Mark Steinmann1, Julika Loss1, Boris Ehrenstein2, Christian Apfelbacher1.   

Abstract

The 'necessity-concerns framework' postulates that patients' adherence behaviour is influenced by beliefs about the necessity and the concerns patients have regarding their prescribed medicines. We hypothesized that depression moderates the associations between beliefs about medicines and medication adherence among people with rheumatoid arthritis. Using multivariate logistic regression, we observed that people experiencing more depressive symptoms showed stronger associations between necessity beliefs and adherence as well as attenuated associations between concerns and adherence, respectively, in a cross-sectional sample ( N = 361). Thus, depression moderates the associations postulated in the 'necessity-concerns framework' in a differential way in people with rheumatoid arthritis.

Entities:  

Keywords:  beliefs about medicines; depression; medication adherence; rheumatoid arthritis

Mesh:

Year:  2016        PMID: 27151068     DOI: 10.1177/1359105316646440

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  5 in total

1.  Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Edward L Barnes; Millie D Long; Kelly C Cushing; Joseph Galanko; Christopher F Martin; Laura E Raffals; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

2.  Pain, social support and depressive symptoms in patients with rheumatoid arthritis: testing the stress-buffering hypothesis.

Authors:  Susanne Brandstetter; Gertraud Riedelbeck; Mark Steinmann; Boris Ehrenstein; Julika Loss; Christian Apfelbacher
Journal:  Rheumatol Int       Date:  2017-01-25       Impact factor: 2.631

Review 3.  The Link Between Autonomic Nervous System and Rheumatoid Arthritis: From Bench to Bedside.

Authors:  Francesca Ingegnoli; Massimiliano Buoli; Flavia Antonucci; Lavinia Agra Coletto; Cecilia Maria Esposito; Roberto Caporali
Journal:  Front Med (Lausanne)       Date:  2020-12-07

4.  Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.

Authors:  Martin P Paulus; Rayus Kuplicki; Teresa A Victor; Hung-Wen Yeh; Sahib S Khalsa
Journal:  BMC Psychiatry       Date:  2021-11-19       Impact factor: 3.630

5.  Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial.

Authors:  Nichapa Taibanguay; Sumapa Chaiamnuay; Paijit Asavatanabodee; Pongthorn Narongroeknawin
Journal:  Patient Prefer Adherence       Date:  2019-01-11       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.